SUBSCRIBE
SUBSCRIBE

Dimension Therapeutics

NEWS
Dimension Therapeutics was acquired by Ultragenyx in 2017.
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Deals
Bay Area’s Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics
September 18, 2017
 · 
3 min read
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
Deals
Troubled Dimension Therapeutics Sold in All-Stock Deal
August 25, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Business
Dimension Therapeutics Pink Slips 25% of Workforce
June 27, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Cambridge’s Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data
February 1, 2017
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioCapital
3 Biotech Stocks Flying High Under-the-Radar
May 26, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Job Trends
Like Dimension Therapeutics, More Than Half of Yumanity’s Employees are Women
February 11, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Genetown
Cambridge’s Dimension Therapeutics Nabs $65 Million
April 21, 2015
 · 
2 min read
AWARDS
  • NextGen Class of 2015
IN THE PRESS
Deals
Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics
November 7, 2017
 · 
4 min read
Astellas and Universal Cells Ink $124M R&D Pact fo
Deals
Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension
October 26, 2017
 · 
6 min read
Deals
Ultragenyx To Acquire Dimension Therapeutics
October 3, 2017
 · 
10 min read
Deals
REGENXBIO Officially Backs Out Of Dimension Therapeutics Deal, Gets $2.85 Million Break Up Fee
October 3, 2017
 · 
7 min read
Deals
REGENXBIO Responds To Notification Of A Superior Proposal Under Its Merger Agreement With Dimension Therapeutics
October 2, 2017
 · 
3 min read
Deals
Ultragenyx Comments On Dimension Therapeutics’ Announcement That Ultragenyx’s Offer Is A “Superior Proposal”
October 2, 2017
 · 
5 min read
Deals
Dimension Therapeutics Board Of Directors Determines Proposal From Ultragenyx Could Reasonably Be Expected To Lead To A “Superior Proposal”
September 19, 2017
 · 
7 min read
Drug Development
Dimension Therapeutics Commences Patient Dosing In Global, Multi-Center Phase I/II Clinical Trial Of DTX301 In Ornithine Transcarbamylase (OTC) Deficiency
August 31, 2017
 · 
8 min read
Deals
REGENXBIO To Acquire Dimension Therapeutics
August 25, 2017
 · 
12 min read
Business
Dimension Therapeutics Reports Second Quarter 2017 Financial Results And Provides Corporate Update
August 8, 2017
 · 
1 min read
Load More